期刊文献+

肺动脉导管在妊娠合并肺动脉高压患者围产期的应用 被引量:2

The application of peripartum use of pulmonary artery catheter in pregnant patients with pulmonary hypertension
原文传递
导出
摘要 目的 探讨肺动脉导管(PAC)在妊娠合并肺动脉高压患者围产期的应用,为PAC在此类患者中的应用提供参考.方法 回顾性分析2006-2014年首都医科大学附属北京安贞医院综合外科ICU收治的妊娠合并肺动脉高压患者的临床资料,比较留置与未留置PAC患者的临床及预后.结果 术前超声心动图测量肺动脉收缩压,留置PAC患者为(103.0±24.1) mmHg(1 mmHg =0.133kPa),未留置PAC患者为(96.4 ±27.3) mmHg,差异无统计学意义(P=0.175).超声心动图测量肺动脉压与PAC测量肺动脉压比,有高估或低估的可能,差值波动在-38.4 ~ 49.5 mmHg.与未留置PAC患者比,留置PAC患者特发性肺动脉高压比例较高(20.0%比3.2%);术中采用连续硬膜外麻醉比例高(89.1%比65.1%);去甲肾上腺素、多巴酚丁胺、西地那非、前列地尔、伊洛前列素及低分子肝素的使用较多;病死率较高(16.4%比3.2%);低体重儿(63.9%比30.6%)、极低体重儿(19.4%比13.9%)的比例较高;人工流产比例略低(5.5%比17.5%).留置PAC患者术后ICU停留时间[6.0(5.0)d比1.0(3.0)d]、术后住院时间[8.0(6.0)d比8.0(4.0)d]、总住院费用[43 999.22(38 267.27)元比14 878.24(10 564.47)元]高于未留置PAC患者.PAC相关并发症的发生率为7.3%.结论 对临床症状较重的妊娠合并中、重度肺动脉高压患者留置PAC,有利于围产期持续肺动脉压监测及指导药物治疗,以改善患者的临床结局,降低短期病死率,而超声心动图测量肺动脉压不能替代PAC在肺动脉压监测中的地位. Objective To investigate the application and value of pulmonary artery catheterization (PAC) in pregnant patients with pulmonary hypertension (PH).Methods The clinical data of pregnant patients with PH who were treated between 2006 and 2014 in surgical intensive care unit (SICU) at Capital Medical University affiliated Beijing Anzhen Hospital were retrospectively analysed.The differences of the clinical characteristics and outcome between PAC inserted patients and PAC not inserted patients were compared.Results The systolic pulmonary artery pressure (sPAP) measured by preoperative echocardiography has no significant difference between the PAC inserted patients [(103.0 ± 24.1) mmHg (1 mmHg =0.133 kPa)] and PAC not inserted patients [(96.4 ±27.3)mmHg;P =0.175].SPAP may be overestimated or underestimated by echocardiography compared with PAC with a gap from-38.4 mmHg to 49.5 mmHg.The rates of idiopathic pulmonary arterial hypertension (20.0% vs 3.2%) and continuous use of epidural anesthesia (89.1% vs 65.1%) were higher in PAC inserted patients compared with PAC not inserted patients.Norepinephrine,dobutamine,sildenafil,alprostadil,iloprost and low molecular weight heparin were more widely used in PAC inserted patients.The mortality rate and the rates of low birth weight (63.9% vs 30.6%) and very low birth weight infants (19.4% vs 13.9%) were all higher in PAC inserted patients,while the rate of induced abortion was lower in this group (5.5% vs 17.5%).The length of stay in surgical intensive care unit [6.0 (5.0) d vs 1.0 (3.0) d],postoperative length of stay [8.0 (6.0) d vs 8.0 (4.0) d] and total hospital costs [43 999.22 (38 267.27)RMB vs 14 878.24 (10 564.47) RMB] were all higher in PAC inserted patients.The incidence rate of PAC related complications was 7.3%.Conclusions In moderate or severe PH pregnant patients with severe clinical symptoms,perioperative insertion of PAC helps to monitor the perinatal pulmonary arterial pressure (PAP) and guide treatment,potentially improving clinical outcomes and lowering the short term mortality.PAC can't be replaced by echocardiography in measuring PAP.
出处 《中华内科杂志》 CAS CSCD 北大核心 2015年第9期773-777,共5页 Chinese Journal of Internal Medicine
基金 首都医学发展科研基金(2009-2073)
关键词 高血压 肺性 妊娠 肺动脉导管 围手术期 Hypertension,pulmonary Pregnancy Pulmonary artery catheter Perioperative period
  • 相关文献

参考文献13

  • 1Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension : the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) [ J ]. Eur Heart J, 2009_ 30(20).2493-2537.
  • 2Weiss BM, Zemp L, Seifert B, et al. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996 [J]. J Am Coil Cardiol, 1998, 31 (7) :1650-1657.
  • 3Bonnin M, Mercier FJ, Sitbon O, et al. Severe pulmonary hypertension during pregnancy: mode of delivery and anesthetic management of 15 consecutive cases [ J]. Anesthesiology, 2005, 102(6) :1133-1137.
  • 4Bedard E, Dimopoulos K, Gatzoulis MA. Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? [ J ]. Eur Heart J, 2009, 30 (3) :256-265.
  • 5Jars X, Olsson KM, Barbera JA, et al. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era [J]. EurRespirJ, 2012, 40(4) :881-885.
  • 6Curry RA, Fletcher C, Gelson E, et al. Pulmonary hypertension and pregnancy-a review of 12 pregnancies in nine women [ J ]. BJOG, 2012, 119(6) :752-761.
  • 7Kiely DG, Condliffe R, Webster V, et al. Improved survival in pregnancy and pulmonary hypertension using a multiprofessional approach [J]. BJOG, 2010, 117(5) :565-574.
  • 8Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy:the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC) [Jl. EurHeartJ, 2011, 32(24) :3147-3197.
  • 9Safdar Z. Pulmonary arterial hypertension in pregnant women [J]. TherAdvRespirDis, 2013, 7(1) :51-63.
  • 10Montani D, Chaumais MC, Guignabert C, et al. Targeted therapies in pulmonary arterial hypertension [ J ]. Pharmacol Ther, 2014, 141 (2) :172-191.

同被引文献17

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部